Clinical Study of Post-Finasteride Syndrome launched at Baylor College of Medicine BCM in Houston, Texas. The research, “Genetic and Epigenetic Studies on Post-Finsteride Syndrome Patients,” is being led by Mohit Khera M.D., M.B.A., M.P.H., Assistant Professor of Urology in the Scott Department of Urology and Director of the laboratory for Andrology Research, McNair Medical Institute at BCM.
The study is being used to determine why PFS patients develop sexual dysfunction
PFS is being is occurring in men who have taken the prescription drug Finasteride. PFS has been reported to occur in men who have taken the prescription drug finasteride to treat hair loss (brand name Propecia and generics), or enlarged prostates (Proscar and generics).
Reported symptoms include: loss of libido, erectile dysfunction, Peyronie’s disease, penile shrinkage, gynecomastia, muscle atrophy, cognitive impairment, severely dry skin and depression. The condition has effected thousands of men worldwide and has had life-altering impact on victims, and their families, such as job loss and the breakup of marriages and romantic relationships, while also being linked to suicides.
On July 1, the PFS Foundation announced the funding of its first clinical PFS study, at Brigham and Women’s Hospital BWH in Boston, a teaching affiliate of Harvard Medical School. The study’s aim is to identify causes of the condition at the molecular level. By evaluating sexual and psychological function, assessing hormone levels, measuring penile hemodynamic and sensory parameters, studying androgen receptor genetics and gene expression, and will determine patterns and profiles.
It’s an important study
Patients interest in participating in the study should email Yesenia S. Rodriguez, Administrative Coordinator of Dr. Khera: Yesenia.Rodriguez@bcm.edu.
To get the latest updates from Atlanta Holistic Health Examiner Tina Ranieri ‘click’ the subscribe button above. To view her body of articles ‘click’ Tina Ranieri, National Holistic Health Examiner, or Atlanta Fishing Examiner.